about
Long-term follow-up of patients with NAFLD and elevated liver enzymesComparing hepatic 2D and 3D magnetic resonance elastography methods in a clinical setting - Initial experiences.Consistent intensity inhomogeneity correction in water-fat MRI.Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisSoluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease.Impact of gastric emptying on the pharmacokinetics of ethanol as influenced by cisaprideEffect of high-fat, high-protein, and high-carbohydrate meals on the pharmacokinetics of a small dose of ethanol.Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.Gastroduodenal Changes Two Years After Eradication of Helicobacter pylori in a Population-Based CohortVisual assessment of biliary excretion of Gd-EOB-DTPA in patients with suspected diffuse liver disease - A biopsy-verified prospective study.Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting.Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis.SAF score and mortality in NAFLD after up to 41 years of follow-up.Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.[Drug-induced liver injury from the dietary supplement Fortodol. A manipulated preparation delayed the diagnosis].Natural history of chronic gastritis in a population-based cohort.Influence of age, sex, and Helicobacter pylori infection before and after eradication on gastric alcohol dehydrogenase activity.Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA.The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.Morphological examination of the termination pattern of substance P-immunoreactive nerve fibers in human antral mucosa.Treatment of anaemia in inflammatory bowel disease with iron sucrose.[New reference interval for ALAT does not identify subclinical liver disease. Lower limit than the proposed should be used for medical considerations!].Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.The effects of capsaicin on gastrin secretion in isolated human antral glands: before and after ingestion of red chilli.Transient increase in HDL-cholesterol during weight gain by hyperalimentation in healthy subjects.Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study.Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study.Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up.Effect of oral diclofenac intake on faecal calprotectin.Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variabilityCompartmentation of glutamate and glutamine in the lateral cervical nucleus: further evidence for glutamate as a spinocervical tract neurotransmitterImmunocytochemical evidence for vesicular storage of glutamate in cat spinocervical and cervicothalamic tract terminalsLow-dose aspirin decreases blood alcohol concentrations by delaying gastric emptyingBreath tests for alcohol in gastroesophageal reflux diseaseMorphological support for paracrine inhibition of gastric acid secretion by nitric oxide in humansStatins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up studyDevelopment of an unbiased method for the estimation of liver steatosisSeparation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy
P50
Q29620024-CD7AB7C6-B715-4B11-B87C-3E799EB05D67Q30389303-DAB43703-8872-426C-943F-8EDF558A3BA4Q30865438-3BE20562-6808-4D90-A093-72504CB1D9BEQ33932951-A7CEF126-4FBC-4299-ABE1-61E783695DBFQ34450628-25DD5253-BDB4-4F7E-B15C-9F23C4A92DEDQ36053797-FBA8E284-BE4D-48E7-9B88-6B1E531A6CC1Q36094207-F32A3FA7-0479-45F7-AE7B-803CB0A373ABQ36218142-DEEE4BF3-B1DC-4E48-B358-E11062A31141Q37311746-14E310E3-5DB2-4806-82EC-D264E6457B94Q38367219-0133B379-523D-4C4D-9BB1-12EE89B36102Q38442605-3906ADDB-CDAB-4F10-A3E2-81919DB6A2EBQ38912312-8FF772E7-E58F-47CF-93E2-8FDCBEDE1675Q39402697-FAD667D9-3F49-4AEB-9DA0-79FAA60DB6CEQ42201783-636B84B4-BB9D-4C76-86A1-8357CA49360DQ43120185-A5DEF6B3-5B82-4685-8BDB-275CDB081948Q43151740-D0EAA326-9A76-4A92-87DB-272C4947DB54Q43592741-60F83174-EE9F-49D1-9E22-EBE0C69C93C8Q43609009-9E5C14CB-B8E8-4AA2-A3B3-86E5F968334EQ43845192-3D8E5317-C19E-4528-BCB2-BFA49D36FAF6Q44077185-96F31E42-EB7B-49FC-9E05-C48FEAF32241Q44923562-D3399FC8-719E-4137-8760-BCA8BE844670Q45107087-7A8DE19E-6BDB-4373-A6C6-AB71F593CF18Q46240486-FDAD1D74-3537-4724-BDA3-F512C7606882Q46454175-CBBA6A20-1144-4B0D-B027-EF0D7F69F88EQ47416340-1700BD45-4C6D-45B2-BE8C-D5F71689C42DQ47802250-A37A7E65-98F2-4B59-9D56-E6D40158691BQ50447868-36B9A204-D0CA-48FF-B444-CC3F305A9CA9Q50535809-E79969A4-02D1-44D5-AD14-26774DB9F77BQ53088704-710E1D60-50F1-4538-9CE1-7BFCD307A126Q53125994-0FCDDD65-25B8-4886-B28D-FCB53BDDDCD0Q53610108-3F56818A-ECE0-4442-BBDA-571EB9504D56Q58622704-0AD31E6A-981A-44AA-9B35-0162ACEE7EF1Q71628173-88D8175A-18C8-4FFA-B1B0-0EA0DE2A8A85Q72347068-874B08F6-C2F6-4563-90E2-6D5FC7D3D73BQ74222546-5890ADB3-6EDA-45F9-B6B0-605726BD8D5BQ74587623-47005DB1-8178-40C1-ADD8-BD61EFC557A8Q74598148-18CE9CD2-5053-47C0-A796-3AD81976B489Q80074648-9AB263B6-3647-4BCD-A038-60DE6B096CC7Q80355655-B3085492-2E83-4AC5-8AAC-5C325912FB1AQ80655378-930346B4-53D8-462B-871A-575E266C4005
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stergios Kechagias
@ast
Stergios Kechagias
@en
Stergios Kechagias
@es
Stergios Kechagias
@nl
Stergios Kechagias
@sl
type
label
Stergios Kechagias
@ast
Stergios Kechagias
@en
Stergios Kechagias
@es
Stergios Kechagias
@nl
Stergios Kechagias
@sl
prefLabel
Stergios Kechagias
@ast
Stergios Kechagias
@en
Stergios Kechagias
@es
Stergios Kechagias
@nl
Stergios Kechagias
@sl
P106
P21
P31
P496
0000-0001-7614-739X